176 related articles for article (PubMed ID: 10323079)
1. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
Papla B; Rudnicka L; Dubiel-Bigaj M; Malinowski E
Pol J Pathol; 1998; 49(4):251-65. PubMed ID: 10323079
[TBL] [Abstract][Full Text] [Related]
2. Thymomas and thymic carcinomas. A retrospective investigation with histological reclassification.
Engel P; Pilsgaard B; Francis D
APMIS; 1995 Sep; 103(9):671-8. PubMed ID: 7488389
[TBL] [Abstract][Full Text] [Related]
3. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prognostic features in thymic epithelial tumors.
Kirchner T; Schalke B; Marx A; Müller-Hermelink HK
Thymus; 1989; 14(1-3):195-203. PubMed ID: 2623740
[TBL] [Abstract][Full Text] [Related]
5. An institutional study on thymomas and thymic carcinomas: experience in 77 patients.
Rieker RJ; Muley T; Klein C; Schnabel PA; Herpel E; Meister M; Schirmacher P; Dienemann H; Pfannschmidt J
Thorac Cardiovasc Surg; 2008 Apr; 56(3):143-7. PubMed ID: 18365972
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
[TBL] [Abstract][Full Text] [Related]
7. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
8. DNA-ploidy analysis correlates with the histogenetic classification of thymic epithelial tumours.
Gschwendtner A; Fend F; Hoffmann Y; Krugmann J; Klingler PJ; Mairinger T
J Pathol; 1999 Dec; 189(4):576-80. PubMed ID: 10629561
[TBL] [Abstract][Full Text] [Related]
9. Thymoma: a pathological study of 50 cases.
Vaideeswar P; Padmanabhan A; Deshpande JR; Pandit SP
J Postgrad Med; 2004; 50(2):94-7. PubMed ID: 15235201
[TBL] [Abstract][Full Text] [Related]
10. Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993.
Engel P; Marx A; Müller-Hermelink HK
Pathol Res Pract; 1999; 195(8):565-70. PubMed ID: 10483587
[TBL] [Abstract][Full Text] [Related]
11. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system.
Kuo TT; Lo SK
Hum Pathol; 1993 Jul; 24(7):766-71. PubMed ID: 8319955
[TBL] [Abstract][Full Text] [Related]
12. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
[TBL] [Abstract][Full Text] [Related]
13. Cytology of thymomas: emphasis on morphology and correlation with histologic subtypes.
Chhieng DC; Rose D; Ludwig ME; Zakowski MF
Cancer; 2000 Feb; 90(1):24-32. PubMed ID: 10692213
[TBL] [Abstract][Full Text] [Related]
14. Thymoma--a study of 60 cases in Singapore.
Tan PH; Sng IT
Histopathology; 1995 Jun; 26(6):509-18. PubMed ID: 7665142
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma.
Kirchner T; Schalke B; Buchwald J; Ritter M; Marx A; Müller-Hermelink HK
Am J Surg Pathol; 1992 Dec; 16(12):1153-69. PubMed ID: 1463094
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
[TBL] [Abstract][Full Text] [Related]
17. Histopatholgical spectrum of thymic neoplasms: twelve-year experience at a referral hospital in north India.
Radotra B; Awasthi A; Joshi K; Das A
Indian J Pathol Microbiol; 2006 Jan; 49(1):1-6. PubMed ID: 16625962
[TBL] [Abstract][Full Text] [Related]
18. [Surgical therapy for patients with thymoma or thymic carcinoma; based on WHO classification].
Yoneda S; Matsuzoe D; Kawahara K; Shirakusa T
Kyobu Geka; 2002 Oct; 55(11):926-30. PubMed ID: 12391687
[TBL] [Abstract][Full Text] [Related]
19. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors.
Lardinois D; Rechsteiner R; Läng RH; Gugger M; Betticher D; von Briel C; Krueger T; Ris HB
Ann Thorac Surg; 2000 May; 69(5):1550-5. PubMed ID: 10881840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
